Sofosbuvir (CAS 1190307-88-0) Market by Manufacturers, Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2030 (Recession Impact Analysis)
ID : MRU_
87651 | Date :
Jan, 2023 | Pages :
160 | Region : Global |
Publisher : MRU
The Global Sofosbuvir (CAS 1190307-88-0) Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023 - 2030.
In the global Sofosbuvir (CAS 1190307-88-0) Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
This report focuses on Sofosbuvir (CAS 1190307-88-0) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Sofosbuvir (CAS 1190307-88-0) market size by analysing historical data and future prospect. In Market segmentation by manufacturers, the report covers the following companies- Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co., Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types : Purity ≥ 98%
Purity < 98% In Market segmentation by applications : Adults Patients
Elderly Patients The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Sofosbuvir (CAS 1190307-88-0) Market for the forecast period 2023 - 2030?
• What are the driving forces in the Sofosbuvir (CAS 1190307-88-0) Market for the forecast period 2023 - 2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Sofosbuvir (CAS 1190307-88-0) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2030
1 Study Coverage
1.1 Sofosbuvir (CAS 1190307-88-0) Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type
1.4.2 Purity ≥ 98%
1.4.3 Purity < 98%
1.5 Market by Application
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application
1.5.2 Adults Patients
1.5.3 Elderly Patients
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sofosbuvir (CAS 1190307-88-0) Production
2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue 2015-2030
2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Production 2015-2030
2.1.3 Global Sofosbuvir (CAS 1190307-88-0) Capacity 2015-2030
2.1.4 Global Sofosbuvir (CAS 1190307-88-0) Marketing Pricing and Trends
2.2 Sofosbuvir (CAS 1190307-88-0) Growth Rate (CAGR) 2023 - 2030
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Sofosbuvir (CAS 1190307-88-0) Manufacturers
2.3.2.1 Sofosbuvir (CAS 1190307-88-0) Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Offered
2.3.2.3 Date of Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
2.4 Market Drivers, Trends and Issues
3 Market Size by Manufacturers
3.1 Sofosbuvir (CAS 1190307-88-0) Production by Manufacturers
3.1.1 Sofosbuvir (CAS 1190307-88-0) Production by Manufacturers
3.1.2 Sofosbuvir (CAS 1190307-88-0) Production Market Share by Manufacturers
3.1.3 Global Market Concentration Ratio (CR5 and HHI)
3.2 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers
3.2.1 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2018-2022)
3.2.2 Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Concentration Ratio (CR10 and HHI)
3.3 Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Sofosbuvir (CAS 1190307-88-0) Production by Regions
4.1 Global Sofosbuvir (CAS 1190307-88-0) Production by Regions
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Regions
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions
4.2 North America
4.2.1 North America Sofosbuvir (CAS 1190307-88-0) Production
4.2.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue
4.2.3 Key Players in North America
4.2.4 North America Sofosbuvir (CAS 1190307-88-0) Import & Export
4.3 Europe
4.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Production
4.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Sofosbuvir (CAS 1190307-88-0) Import & Export
4.4 China
4.4.1 China Sofosbuvir (CAS 1190307-88-0) Production
4.4.2 China Sofosbuvir (CAS 1190307-88-0) Revenue
4.4.3 Key Players in China
4.4.4 China Sofosbuvir (CAS 1190307-88-0) Import & Export
4.5 Japan
4.5.1 Japan Sofosbuvir (CAS 1190307-88-0) Production
4.5.2 Japan Sofosbuvir (CAS 1190307-88-0) Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Sofosbuvir (CAS 1190307-88-0) Import & Export
5 Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
5.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Regions
5.2 North America
5.2.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Application
5.2.2 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Application
5.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Application
5.4.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption by Application
5.5.2 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption by Application
5.6.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa
6 Market Size by Type
6.1 Global Sofosbuvir (CAS 1190307-88-0) Breakdown Dada by Type
6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type
6.3 Sofosbuvir (CAS 1190307-88-0) Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Sofosbuvir (CAS 1190307-88-0) Breakdown Dada by Application
7.2.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Application
7.2.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2018-2022)
8 Manufacturers Profiles
8.1 Teva Pharmaceutical Industries Ltd
8.1.1 Teva Pharmaceutical Industries Ltd Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.1.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.1.5 SWOT Analysis
8.2 DONG BANG FUTURE TECH & LIFE CO., LTD
8.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.2.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.2.5 SWOT Analysis
8.3 Beaukev Pharma International Pvt.Ltd
8.3.1 Beaukev Pharma International Pvt.Ltd Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.3.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.3.5 SWOT Analysis
8.4 DEAFARMA
8.4.1 DEAFARMA Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.4.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.4.5 SWOT Analysis
8.5 Tecoland
8.5.1 Tecoland Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.5.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.5.5 SWOT Analysis
8.6 Anhui HaiKang Pharmaceutical Co. Ltd
8.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.6.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.6.5 SWOT Analysis
8.7 Shanghai Haoyuan Chemexpress Co., Ltd
8.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.7.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.7.5 SWOT Analysis
8.8 Beijing Kawin Technology Share-holding Co
8.8.1 Beijing Kawin Technology Share-holding Co Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.8.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.8.5 SWOT Analysis
8.9 Hangzhou Longshine Bio-Tech Co
8.9.1 Hangzhou Longshine Bio-Tech Co Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
8.9.4 Sofosbuvir (CAS 1190307-88-0) Product Description
8.9.5 SWOT Analysis
9 Production Forecasts
9.1 Sofosbuvir (CAS 1190307-88-0) Production and Revenue Forecast
9.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast 2023 - 2030
9.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast 2023 - 2030
9.2 Sofosbuvir (CAS 1190307-88-0) Production and Revenue Forecast by Regions
9.2.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions
9.2.2 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Regions
9.3 Sofosbuvir (CAS 1190307-88-0) Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Type
9.4.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2023 - 2030
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2023 - 2030
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Regions 2023 - 2030
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country 2023 - 2030
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2023 - 2030
10.7.2 Turkey
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Sofosbuvir (CAS 1190307-88-0) Upstream Market
11.1.1 Sofosbuvir (CAS 1190307-88-0) Key Raw Material
11.1.2 Typical Suppliers of Key Sofosbuvir (CAS 1190307-88-0) Raw Material
11.1.3 Sofosbuvir (CAS 1190307-88-0) Raw Material Market Concentration Rate
11.2 Sofosbuvir (CAS 1190307-88-0) Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Sofosbuvir (CAS 1190307-88-0) Distributors
11.5 Sofosbuvir (CAS 1190307-88-0) Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porters Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.